Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment

Recruiting now · Phase 3

Conditions studied: Smoking Cessation

In brief

This study will evaluate the efficacy of extended bupropion(6 months) versus standard bupropion treatment (7 weeks) among African American daily smokers.

Key facts

Study ID
NCT05732272
Run by
University of Kansas Medical Center
People needed
500
Starts
2023-02-28
Expected to finish
2027-04-30
Last updated by the study team
2026-02-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.